These findings highlight the role of TRPV1 in regulating lipid metabolism and suggest that dietary CAP improves dyslipidemia in a TRPV1-dependent manner, potentially mitigating one of the key metabolic risk factors for MASLD. Here, TRPV1 is linked to metabolic syndrome.